A striking disconnect defines how Wall Street currently prices Oklo (NYSE: OKLO): the company’s enterprise value sits at just $1.9 billion against a total market capitalization of $4.4 billion.
That gap means investors are essentially paying for the cash pile and ascribing almost no value to the Aurora reactor program the company has spent years building.
Yet shares surged 22.7% to close at $24 on Friday, lifted by a better-than-expected quarterly loss and a new domestic manufacturing agreement that grabbed attention across the nuclear sector.
The third quarter produced a net loss of $41.7 million, wider than the $29.7 million recorded a year earlier, but the per-share figure of $0.22 came in well below the $0.27 analysts had penciled in.
Revenue reached $1.86 million for the period, nearly doubling the $1.01 million consensus estimate, with interest income from a substantial cash position doing considerable heavy lifting.
Cash and marketable securities grew to $3.13 billion as of September 30, up from $3.0 billion at the end of June, after Oklo completed stock sales under a May equity program and launched a fresh $1 billion program with ten sales agents on September 11.
With roughly 186 million shares now outstanding, that ongoing dilution at prices far below earlier levels is a genuine concern for existing holders.
The manufacturing agreement with U.S. Forged Rings reserves production capacity for large components including reactor vessels, lids, and support structures sufficient for 27 Aurora modules, sourced from a planned facility in Hertford County, North Carolina.
First deliveries under that arrangement are not expected until 2030, and critically, not a single binding power purchase contract has been signed to fill that reserved capacity.
NuScale Power (NYSE: SMR) rallied 16.3% on the same session, reflecting a broader sentiment shift toward small modular reactor developers after both companies posted smaller losses than the market feared.
The shared enthusiasm is understandable given how severely both stocks were sold off, with Oklo still trading roughly 80% below its 52-week high of $117 even after Friday’s dramatic bounce.
Progress on the ground at Idaho National Laboratory, where structural work on the first Aurora plant has begun and a first full fuel assembly is targeted for 2027, offers a concrete milestone but also underscores how far away commercial revenue remains.
Analysts tracking the company project only around $122 million in revenue for 2029, a modest figure relative to the capacity being reserved for 27 modules.
The longer-term cash picture is more daunting: analysts anticipate roughly $6.3 billion in free cash outflows between 2026 and 2030, approximately double what Oklo currently holds.
A Meta prepayment tied to an Ohio campus of up to 1.2 gigawatts represents the most tangible demand signal, but the absence of a formal contract keeps that commitment in uncertain territory.
Oklo maintained its 2026 capital expenditure guidance of $400 million to $500 million, and the operating loss of $71.0 million in the third quarter edged slightly below the $73.2 million recorded in the second quarter.
NuScale’s parallel situation illustrates just how speculative the sector remains, with the company carrying a $2.1 billion market value against $1.9 billion in cash and investments, leaving investors paying almost exclusively for future optionality.
The next major information event is a fiscal year report expected on March 17, which should clarify Aurora-INL’s cost trajectory, fuel assembly progress, and the extent of additional share issuance.
Until a binding revenue contract materializes, the manufacturing capacity reserved for 27 reactors remains a forward bet on orders that have yet to arrive.
